ClinicalTrials.gg
CompletedNCT03272906Updated Mar 21, 2024

Clinical Feasibility of Transcranial Direct Current Stimulation [tDCS] With Standard Aphasia Therapy

An interventional study of Anodal transcranial direct current stimulation and Sham transcranial direct current stimulation in Aphasia and Stroke, sponsored by Louisiana State University and A&M College. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-03-21.

Sponsored by Louisiana State University and A&M College · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Jun 2021, 5 years 4 months ago, and no results have been posted to the registry.
Phase
Not applicable
Study type
Interventional
Enrollment
7
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Study Design: This is a within-subjects crossover design. Subjects will participate in the procedures twice, once under each condition (active vs. sham stimulation). The order of conditions will be counter-balanced across subjects. Stimulation will target ventral inferior frontal gyrus (IFG) and will be paired with standard speech-language therapy. Outcome measures will be acquired at the beginning and end of a semester of standard speech-language therapy.

Read the detailed description

Baseline Behavioral Assessment: Medical and neurological history will be taken. Western Aphasia Battery-Revised, Communication Activities of Daily Living-2, and Philadelphia Naming Test (short form) will be administered. Narrative will be elicited (Cinderella story). Some of these procedures will be videorecorded for later transcription. Subjects will also complete a pre-tDCS safety screening questionnaire.

tDCS: Participants will undergo placement of 2 tDCS electrodes. For all subjects, the anodal electrode will be placed at the following locations (EEG 10-20 system):

(i) over the left inferior frontal gyrus (crossing point between T3-Fz and F7-Cz)

The cathodal electrode will be placed at the second site:

(ii) over right frontal pole (Fp2)

Two types of stimulation will be given, an active condition and a sham condition. In the sham condition, stimulation is ramped up over the first 30 seconds (as in the active condition), but then discontinued. This gives the physical perception of stimulation without the modulatory effects.

Stimulation will be delivered by a tDCS device with the following parameters for intensity and duration:

  • Intensity: 2 mA
  • Duration: 20 minutes

tDCS will be provided for the first 20 minutes of each aphasia therapy session provided at the LSU Speech-Language-Hearing Clinic. The therapy sessions last for one hour and are provided twice weekly for 8 weeks over the course of an academic semester (fall and spring).

Post-Therapy/Stimulation Assessment: Western Aphasia Battery-Revised, Communication Activities of Daily Living-2, and Philadelphia Naming Test (short form) will be administered as before therapy. Cinderella narrative will again be elicited. Some of these procedures will again be videorecorded for later transcription. A tDCS sensations survey will also be completed at the final assessment to determine the effectiveness of blinding.

02

Conditions studied

  • Aphasia
  • Stroke

Keywords

  • aphasia
  • stroke
  • tDCS
  • language
  • stimulation
  • brain
  • speech therapy
03

In context

Aphasia

338 studies on the registry are indexed under Aphasia; 95 are open to participants now.

This study's enrollment of 7 is below the median of 30 across 298 interventional studies indexed under Aphasia.

Browse Aphasia studies →

Lead sponsor

Louisiana State University and A&M College is the lead sponsor of 13 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Single, unilateral stroke resulting in aphasia
  • Competency to provide written
  • Ability to participate in standard aphasia therapy

Exclusion criteria

Exclusion Criteria:

  • Serious psychological condition
  • Serious neurological condition, other than stroke
  • Serious medical condition
  • Pregnancy
  • History of seizures
  • Presence of electronic or metal implants (e.g., pacemaker, vagal nerve stimulator, etc.).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
7 participants (actual)

Study arms

  • Experimental
    A-tDCS & speech-language therapy

    Anodal transcranial direct current stimulation (2 mA) plus speech-language therapy for 16 sessions (20-minutes per each 60-minute treatment session) over the course of 8 weeks. The electrical current will be administered over ventral inferior frontal gyrus. The stimulation will be delivered at an intensity of 2mA for a maximum of 20 minutes.

    Device: Anodal transcranial direct current stimulation · Behavioral: Speech-language therapy

  • Sham comparator
    Sham-tDCS & speech-language therapy

    Sham transcranial direct current stimulation (2 mA) plus speech-language therapy for 16 sessions (20-minutes per each 60-minute treatment session) over the course of 8 weeks. Electrodes will be placed as in A-tDCS. Current will be ramped up for the first 30 seconds following which the intensity will drop to 0 mA.

    Device: Sham transcranial direct current stimulation · Behavioral: Speech-language therapy

Interventions

  • DeviceAnodal transcranial direct current stimulation

    2 mA of A-tDCS stimulation is induced between two 5 cm x 7 cm saline soaked sponges where one sponge (anode: A-tDCS) is placed on the scalp over the targeted cortical region. Ramping up of the current to 2 mA occurs over 30 seconds to allow participants to habituate to the tingling sensation. A-tDCS stimulation will be active only in the first 20 minutes of the 60-minute treatment session.

    Also known as: (A-tDCS)

  • DeviceSham transcranial direct current stimulation

    2 mA of A-tDCS stimulation is induced between two 5 cm x 7 cm saline soaked sponges where one sponge (anode: A-tDCS) is placed on the scalp over the targeted cortical region. Ramping up of the current to 2 mA occurs over 30 seconds to allow participants to habituate to the tingling sensation. Then, the current will be ramped back down to 0 mA in the sham condition.

    Also known as: Sham

  • BehavioralSpeech-language therapy

    Therapy tasks will be determined by the clinician on an individualized basis and will not be affected by this research protocol. The only difference between the clinical therapy that is normally provided in the clinic and this research paradigm is the application of tDCS electrodes during therapy. Therapist is blinded to stimulation type.

    Also known as: SLT

06

What researchers measure

Primary outcomes

  1. Production of Correct Information Units (CIUs) in Cinderella narrative

    Change in CIU production over treatment interval. Words are counted as CIUs if they are novel, intelligible, and appropriate in context

    Time frame: Following 8 weeks of speech-language therapy

Secondary outcomes

  1. Western Aphasia Battery-Revised (WAB-R)

    Change in performance on Part 1 of WAB-R (Aphasia Quotient)

    Time frame: Following 8 weeks of speech-language therapy

  2. Communication Activities of Daily Living-2 (CADL-2)

    Change in performance on CADL-2

    Time frame: Following 8 weeks of speech-language therapy

  3. Philadelphia Naming Test - Short Form (PNT)

    Change in performance on PNT

    Time frame: Following 8 weeks of speech-language therapy

07

Study locations

1 site
  • Louisiana State University
    Baton Rouge, Louisiana 70803, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03272906
Lead sponsor
Louisiana State University and A&M College
Responsible party
E. Susan Duncan (Assistant Professor, Louisiana State University and A&M College) — Principal investigator
First posted
Sep 6, 2017
Start date
Aug 31, 2017
Primary completion
Jun 30, 2021
Completion
Jun 30, 2023
Last update
Mar 21, 2024

Study contacts

E. Susan Duncan, PhD, CCC-SLP
principal investigator · Lousiana State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion